{"id":"https://openalex.org/W4388080633","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0545","title":"545 ATX/LPA upregulation via microRNA-29 loss suppresses cytotoxic T cells and promotes resistance to anti-PD-1 in non-small cell lung cancer","display_name":"545 ATX/LPA upregulation via microRNA-29 loss suppresses cytotoxic T cells and promotes resistance to anti-PD-1 in non-small cell lung cancer","publication_year":2023,"publication_date":"2023-10-31","ids":{"openalex":"https://openalex.org/W4388080633","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0545"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2023-sitc2023.0545","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0545","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.0545","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/A619.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/A619.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019218539","display_name":"Jessica Marie Konen","orcid":"https://orcid.org/0000-0002-8391-3045","observed_orcids":["https://orcid.org/0000-0002-8391-3045"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jessica M Konen","raw_affiliation_strings":["Emory University, Atlanta, GA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory University, Atlanta, GA, USA","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029229347","display_name":"B. Leticia Rodriguez","orcid":"https://orcid.org/0000-0001-8406-7509","observed_orcids":["https://orcid.org/0000-0001-8406-7509"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B Leticia Rodriguez","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101353018","display_name":"Haoyi Wu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Haoyi Wu","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078178224","display_name":"Jared J. Fradette","orcid":"https://orcid.org/0000-0001-6712-2860","observed_orcids":["https://orcid.org/0000-0001-6712-2860"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jared Fradette","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042916524","display_name":"Laura Gibson","orcid":"https://orcid.org/0000-0003-1668-6898","observed_orcids":["https://orcid.org/0000-0003-1668-6898"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura Gibson","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089771018","display_name":"Lixia Diao","orcid":"https://orcid.org/0000-0001-6995-4492","observed_orcids":["https://orcid.org/0000-0001-6995-4492"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lixia Diao","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100378341","display_name":"Jing Wang","orcid":"https://orcid.org/0000-0002-5398-0802","observed_orcids":["https://orcid.org/0000-0002-5398-0802","https://orcid.org/0009-0006-4171-5397","https://orcid.org/0000-0002-8911-9555","https://orcid.org/0009-0003-0661-5954"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jing Wang","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005831187","display_name":"Stephanie Schmidt","orcid":"https://orcid.org/0000-0003-3560-5782","observed_orcids":["https://orcid.org/0000-0003-3560-5782"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephanie Schmidt","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028085268","display_name":"Ignacio Ivan Wistuba","orcid":"https://orcid.org/0000-0003-3365-6340","observed_orcids":["https://orcid.org/0000-0003-3365-6340"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ignacio Wistuba","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100358178","display_name":"Jianjun J. Zhang","orcid":"https://orcid.org/0000-0001-7872-3477","observed_orcids":["https://orcid.org/0000-0001-7872-3477"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jianjun Zhang","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010884206","display_name":"Don Lynn Gibbons","orcid":"https://orcid.org/0000-0003-2362-3094","observed_orcids":["https://orcid.org/0000-0003-2362-3094"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Don Gibbons","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A619","last_page":"A619"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11308","display_name":"Sphingolipid Metabolism and Signaling","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10062","display_name":"MicroRNA in disease regulation","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/autotaxin","display_name":"autotaxin","score":0.906000018119812},{"id":"https://openalex.org/keywords/lysophosphatidic-acid","display_name":"lysophosphatidic acid","score":0.9980000257492065},{"id":"https://openalex.org/keywords/microrna-29","display_name":"microRNA-29","score":0.9020000100135803},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-resistance","display_name":"immune checkpoint inhibitor resistance","score":0.703000009059906},{"id":"https://openalex.org/keywords/anti-pd-1-resistance","display_name":"anti-PD-1 resistance","score":0.8989999890327454},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9240000247955322},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.7350000143051147},{"id":"https://openalex.org/keywords/cd8-t-cell-suppression","display_name":"CD8+ T cell suppression","score":0.7630000114440918},{"id":"https://openalex.org/keywords/lpar5","display_name":"LPAR5","score":0.7480000257492065},{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.6069999933242798},{"id":"https://openalex.org/keywords/tim-3","display_name":"TIM-3","score":0.8399999737739563},{"id":"https://openalex.org/keywords/3-utr-regulation","display_name":"3' UTR regulation","score":0.7009999752044678},{"id":"https://openalex.org/keywords/patient-derived-organoids","display_name":"patient-derived organoids","score":0.7710000276565552}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6941287517547607},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.6023903489112854},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.5895065665245056},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5274774432182312},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5159586071968079},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4995124340057373},{"id":"https://openalex.org/C37547375","wikidata":"https://www.wikidata.org/wiki/Q14913997","display_name":"Autotaxin","level":4,"score":0.47686609625816345},{"id":"https://openalex.org/C2776661833","wikidata":"https://www.wikidata.org/wiki/Q2823281","display_name":"Lysophosphatidic acid","level":3,"score":0.46718791127204895},{"id":"https://openalex.org/C145059251","wikidata":"https://www.wikidata.org/wiki/Q310899","display_name":"microRNA","level":3,"score":0.45261555910110474},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.45020240545272827},{"id":"https://openalex.org/C162317418","wikidata":"https://www.wikidata.org/wiki/Q252857","display_name":"Transcriptome","level":4,"score":0.44583746790885925},{"id":"https://openalex.org/C2779256057","wikidata":"https://www.wikidata.org/wiki/Q16909647","display_name":"Tumor progression","level":3,"score":0.43841394782066345},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.41951116919517517},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.4184766411781311},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.4172621965408325},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.31848806142807007},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2836742401123047},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2552203834056854},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.23369422554969788},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2045970857143402},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.1272793710231781},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.10331931710243225},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2023-sitc2023.0545","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0545","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.0545","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/A619.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:7e400a6ece96446abdebcaf1a9c03ace","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/7e400a6ece96446abdebcaf1a9c03ace","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2023-sitc2023.0545","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0545","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.0545","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/A619.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4388080633.pdf","grobid_xml":"https://content.openalex.org/works/W4388080633.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4308378361","https://openalex.org/W7131400349","https://openalex.org/W4386317034","https://openalex.org/W4380450124","https://openalex.org/W4393093691","https://openalex.org/W7212012985","https://openalex.org/W1533107225","https://openalex.org/W4407866402","https://openalex.org/W4362592579","https://openalex.org/W4379984460"],"abstract_inverted_index":{"Background":[0],"Immune":[1],"checkpoint":[2],"inhibitors":[3],"(ICI)":[4],"have":[5],"revolutionized":[6],"oncological":[7],"treatment":[8],"strategies":[9],"for":[10],"many":[11,264],"tumor":[12,151,212,346],"types,":[13],"including":[14,267],"non-small":[15],"cell":[16,305,319],"lung":[17,64,131,193],"cancer":[18,65,440],"(NSCLC),":[19],"in":[20,26,55,173,187,211,242,334,337,340,359,368,493,506],"which":[21,278],"response":[22,40,100],"rates":[23],"are":[24],"~35%":[25],"patients":[27,37],"harboring":[28],"KRAS":[29],"and":[30,94,101,126,147,153,161,205,254,270,307,322,336,426,451,480,491],"TP53":[31],"(KP)":[32],"mutations.":[33],"While":[34],"promising,":[35],"most":[36],"demonstrate":[38,66],"no":[39],"or":[41,327,432],"develop":[42],"resistance":[43,82,102],"while":[44],"on":[45,150,288],"treatment,":[46],"underscoring":[47],"the":[48,56,112,141,162,178,221,243,275,328,412,415,433,446,472,499,517],"need":[49],"to":[50,69,79,110,139,169,220,281],"better":[51],"define":[52,111],"suppressive":[53,255,265],"mechanisms":[54],"tumor-immune":[57,113],"microenvironment.":[58],"Experimental":[59],"murine":[60],"models":[61,128],"of":[62,118,129,143,182,191,209,313,365,373,414,417,461,476,484,501,516],"KP":[63,92,130],"upfront":[67],"sensitivity":[68],"PD-1":[70,269],"blockade":[71],"but":[72],"rapidly":[73],"acquire":[74],"resistance,":[75],"providing":[76,223,392],"useful":[77],"tools":[78],"analyze":[80],"tumor-intrinsic":[81],"mechanisms.":[83],"Methods":[84],"We":[85,122],"analyzed":[86],"transcriptome":[87],"data":[88,157,258,350,492],"from":[89],"anti-PD-L1":[90],"treated":[91],"tumors":[93,290,360],"identified":[95,158],"differentially":[96],"expressed":[97,172],"genes":[98],"between":[99,203],"timepoints.":[103],"Additionally,":[104],"we":[105,238,283],"performed":[106,284],"multiparameter":[107],"flow":[108,285],"cytometry":[109],"microenvironment":[114,343],"with":[115,148,235,246,263,292,302,332,361,397],"manipulated":[116,293],"expression":[117,217,241,299,312,358],"candidate":[119],"gene":[120,249],"expression.":[121],"also":[123],"utilized":[124],"syngeneic":[125],"autochthonous":[127],"cancer,":[132],"as":[133,135,388,514],"well":[134],"patient-derived":[136],"organoids":[137],"(PDOs),":[138],"test":[140],"efficacy":[142],"targeted":[144],"agents":[145],"alone":[146],"anti-PD-1":[149,333],"growth":[152],"metastasis.":[154],"Results":[155],"Our":[156,349],"autotaxin":[159],"(ATX)":[160],"metabolite":[163],"it":[164,396],"generates,":[165],"lysophosphatidic":[166],"acid":[167],"(LPA),":[168],"be":[170],"highly":[171],"ICI":[174,362,398],"resistant":[175,188],"tumors.":[176,189],"Conversely,":[177],"predicted":[179],"post-transcriptional":[180],"regulator":[181],"ATX,":[183,206],"miR-29,":[184],"was":[185],"downregulated":[186],"Analysis":[190,483],"TCGA":[192],"adenocarcinoma":[194],"(LUAD)":[195],"patient":[196,441],"datasets":[197],"revealed":[198,259],"a":[199,228,341],"significant":[200],"negative":[201],"correlation":[202],"miR-29":[204,210,226,353],"whereas":[207],"re-expression":[208],"cells":[213,376],"directly":[214,315],"repressed":[215],"ATX":[216,230,234,240,260,294,326],"via":[218,377],"binding":[219],"3\u2019UTR,":[222],"evidence":[224,383],"that":[225,297,352,384,394],"is":[227],"bonafide":[229],"regulator.":[231],"To":[232,272],"link":[233],"immune":[236,248,252,402],"functionality,":[237],"correlated":[239,262,301],"LUAD":[244],"dataset":[245],"an":[247,389],"signature":[250],"encompassing":[251],"checkpoints":[253],"molecules.":[256],"These":[257,380],"positively":[261],"molecules,":[266],"PD-L1,":[268],"TIM-3.":[271],"further":[273],"understand":[274],"mechanism":[276],"by":[277],"ATX/LPA":[279,357],"contributes":[280],"immunosuppression,":[282],"cytometric":[286],"analyses":[287],"isogenic":[289],"pairs":[291],"expression,":[295],"finding":[296],"its":[298],"inversely":[300],"CD8+":[303,374],"T":[304,318,375],"proliferation":[306],"cytotoxic":[308],"functionality.":[309],"Similarly,":[310],"exogenous":[311],"LPA":[314],"diminished":[316],"effector":[317],"cytokine":[320],"secretion":[321],"differentiation.":[323],"Lastly,":[324],"co-targeting":[325,395],"downstream":[329],"LPAR5":[330,378],"receptor":[331],"vivo":[335],"PDOs":[338],"embedded":[339],"3-D":[342],"significantly":[344],"inhibited":[345],"progression.":[347],"Conclusions":[348],"indicate":[351],"loss":[354],"drives":[355],"aberrant":[356],"resistance.":[363],"Overexpression":[364],"this":[366,385,494,507],"axis":[367,386],"turn":[369],"diminishes":[370],"cytolytic":[371],"functions":[372],"signaling.":[379],"results":[381],"provide":[382],"acts":[387],"immunosuppressive":[390],"checkpoint,":[391],"rationale":[393],"should":[399],"improve":[400],"anti-tumor":[401],"responses.":[403],"Ethics":[404],"Approval":[405],"All":[406,489],"animal":[407],"studies":[408],"were":[409,443,496],"completed":[410],"under":[411,445,498],"approval":[413],"University":[416,435,478],"Texas":[418],"MD":[419],"Anderson":[420],"Cancer":[421,468,474,487],"Center":[422],"Institutional":[423],"Animal":[424],"Care":[425,469],"Use":[427,460],"Committee":[428],"(IACUC)":[429],"(protocol":[430,437],"#1271)":[431],"Emory":[434,477,485],"IACUC":[436],"#201700322).":[438],"Lung":[439,450,486],"specimens":[442,490],"collected":[444,497],"following":[447],"protocols:":[448],"IRB00009857":[449],"Thoracic":[452],"Malignancies":[453],"Satellite":[454],"Bank,":[455],"IRB00045796":[456],"Storage":[457],"&":[458,463],"Research":[459],"Tissue":[462],"Information,":[464],"IRB00095411":[465],"Winship":[466,473],"Discovery/Total":[467],"biorepository":[470,503,518],"at":[471],"Institute":[475],"(Winship),":[479],"IRB00098377:":[481],"Molecular":[482],"Specimens.":[488],"study":[495,508],"authority":[500],"established":[502],"protocols.":[504],"Participants":[505],"sign":[509],"IRB-approved":[510],"informed":[511],"consent":[512],"forms":[513],"part":[515],"studies.":[519]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2023-11-01T00:00:00"}